Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & ResearchLab & research supplies.Reagents, consumables, PPE & instruments — documented, fast, chain-of-custody shipping.Shop lac.us lac.us

Can You Patent an Idea? The Abstract-Idea Rule Explained

An idea alone is never patentable under U.S. law. Learn why the abstract-idea exception under 35 U.S.C. § 101 exists, what actually turns an idea into a patentable invention, and how to protect an idea before it gets there.

No — under U.S. patent law, an idea by itself is never patentable. What the law protects is a concrete application of an idea: a specific process, machine, article of manufacture, or composition of matter that puts the idea to practical use. This is one of the most common misconceptions researchers and first-time inventors bring to a technology transfer office (TTO), and it has a precise legal basis rather than being a rule of thumb.

The short answer

You cannot patent “a faster way to search the internet” or “a method for curing cancer” as bare concepts. You can patent a specific, described way of achieving that result — the actual steps, structure, or mechanism — once it is worked out in enough detail that someone skilled in the field could build and use it. Between those two points is where most invention disclosures live, and where TTOs spend a lot of their intake conversation.

Why abstract ideas fail 35 U.S.C. § 101

35 U.S.C. § 101 defines what patent law calls “inventions patentable”: any new and useful process, machine, manufacture, or composition of matter. Courts have read three judge-made exceptions into that statute since long before the modern patent system: laws of nature, natural phenomena, and abstract ideas are not eligible for patent protection, no matter how novel or valuable they are. An idea, standing alone, falls into that third category almost by definition — it is not yet a process, machine, manufacture, or composition of matter, it is the concept those things might eventually embody.

The Supreme Court’s Mayo Collaborative Services v. Prometheus Laboratories (2012) and Alice Corp. v. CLS Bank International (2014) decisions set out the two-step framework the U.S. Patent and Trademark Office (USPTO) now applies to every eligibility question: first, is the claim directed to an abstract idea, law of nature, or natural phenomenon; second, if so, do the claim elements — individually or as an ordered combination — add an “inventive concept” that amounts to significantly more than the abstract idea itself. Simply attaching generic implementation language (“on a computer,” “using a database”) to an otherwise abstract idea does not clear that second step. This is the same framework the USPTO’s own examination guidance (MPEP § 2106) uses.

Full mechanics of this test, the statutory text, and worked eligibility examples: 35 U.S.C. § 101: Patentable Subject Matter and the Alice/Mayo Eligibility Test.

What turns an idea into a patentable invention

Patent law distinguishes between conception — forming a definite and permanent idea of a complete invention in your mind — and reduction to practice — actually building/testing the invention (actual reduction to practice) or filing a patent application that describes it in enough detail for someone skilled in the field to make and use it (constructive reduction to practice). A patent application only becomes filable once an idea has been developed to roughly this point. In practice, that usually means you can point to:

  • A specific mechanism or method — not just the problem you want solved, but a particular way of solving it.
  • Enough detail to enable someone else to build and use it without further invention on their part — this is the enablement requirement under 35 U.S.C. § 112, the fourth of the four patentability tests.
  • Something novel that hasn’t already been publicly disclosed, and non-obvious over the existing state of the art — the separate novelty and non-obviousness requirements under §§ 102 and 103, which apply only once an idea has cleared the eligibility threshold in the first place.

The full four-test framework — eligibility, novelty, non-obviousness, and disclosure — is mapped in Patent Law Requirements: The Four Tests an Invention Must Pass.

Common misconceptions this question is really asking about

Can I patent a business idea?

Not on its own. “Methods of organizing human activity” — a category that includes many business methods — are one of the recognized abstract-idea categories under the Alice/Mayo framework. A specific, technically implemented process built around a business concept can still be eligible (the Federal Circuit’s DDR Holdings v. Hotels.com decision is the standard example of eligible computer-implemented claims), but the underlying business concept by itself is not.

Do I need a working prototype before I can apply?

No — constructive reduction to practice (a sufficiently detailed patent application) satisfies the reduction-to-practice requirement without a physical prototype. What you do need is enough concrete detail that the application enables someone skilled in the field to build and use the invention. This is why a provisional patent application is often the right first filing for an idea that’s real but not yet fully engineered: it establishes a priority date and buys 12 months to develop the invention further before a full non-provisional application is due.

What’s the actual difference between “an idea” and “an invention” in patent law?

An idea is the problem or goal (a way to do X). An invention, in the patentable sense, is a specific, described solution (this particular mechanism/process/composition that does X). The gap between the two is exactly what the § 101 abstract-idea exception is drawn to enforce — it keeps the patent system from granting exclusive rights over problems or goals themselves, which would block everyone else from ever solving the same problem a different way.

How to protect an idea before it’s patentable

An idea that isn’t yet concrete enough to patent isn’t unprotectable — it’s protected differently:

  • Keep it confidential. Public disclosure (a conference talk, a preprint, a pitch to an unbound third party) can start the novelty clock running under 35 U.S.C. § 102 even before you’ve filed anything, and in most jurisdictions outside the U.S. there is no grace period at all.
  • Use a non-disclosure agreement before discussing the idea with anyone outside your institution who isn’t already bound by confidentiality obligations — see Non-Disclosure Agreements (NDAs) in Research and Technology Transfer.
  • Document conception — dated lab notebooks, internal memos, or an invention disclosure form create a contemporaneous record of when the idea became concrete enough to describe, which matters for inventorship and priority questions later.
  • File an invention disclosure with your TTO as soon as the idea has taken a specific enough shape to describe a mechanism, not just a goal — a TTO can assess patentability and help decide whether and when a provisional application makes sense.

The practical takeaway

“Can I patent an idea” almost always has a more useful follow-up question behind it: “how developed does this need to be before it’s patentable, and what do I do in the meantime?” The answer is that patent law doesn’t require a finished product — it requires a specific enough description of how the idea actually works that someone else could build and use it. Getting from a goal to that description is the real work of moving an invention disclosure toward a filed application, and it’s exactly what a TTO’s intake and patentability screening process exists to help with.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →